A 54-Year Dividend Streak Meets a $10.9 Billion Acquisition: Here’s Why AbbVie’s Payouts Are Safe Life Science
Anti-Cancer Upstart’s Stock Surges 125% This Year as Billionaire Druckenmiller Builds Large Position Life Science
Raising Dividends for 54 Consecutive Years to Reward Shareholders, Abbott Laboratories’ Diversified Layout Consolidates Its Growth Foundation Life Science
UnitedHealth Group Stock Rises 37% Year-to-Date, Market Sees Path Back to All-Time Highs Life Science
Johnson & Johnson Posts Solid Quarter, Yet Wall Street Sells Off – What Spooked Investors? Life Science
Intuitive Surgical’s Stock Has Fallen Over 25% This Year, but Goldman Sachs Still Recommends Investors Buy Life Science
Two Overhyped GLP-1 Stocks Present Buying Opportunities on Dips, with Novo Nordisk and Kailera Therapeutics Each Offering Unique Highlights Life Science
WELL Health Delivers Record Profits — Is This 53% Discount a Buying Opportunity? Life Science, Technology
The Market Has Responded Coolly to Vertex’s Multibillion-Dollar Acquisition, but Management’s Track Record and Integration Capabilities Add Confidence to the Deal Life Science
